Trademark: 90459479
Word
ADAPTIVE BIOTECHNOLOGIES
Status Date
Tuesday, December 6, 2022
Registration Number
6919052
Registration Date
Tuesday, December 6, 2022
Filing Date
Monday, January 11, 2021
Published for Opposition
Tuesday, September 7, 2021
44 Providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; consulting services in the field of medical diagnostic and prognostic testing; medical analysis services for diagnostic and prognostic testing and treatment purposes; providing medical diagnostic and prognostic testing services; medical analysis services relating to the diagnosis and treatment of person
42 Providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services
The mark consists of the word "Adaptive" with the letter "A" being capitalized and the word "biotechnologies" in lowercase lettering.
"BIOTECHNOLOGIES"
Dec 6, 2022
Notice Of Registration Confirmation Emailed
Dec 6, 2022
Registered-Principal Register
Oct 29, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
Oct 28, 2022
Allowed Principal Register - Sou Accepted
Oct 27, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 26, 2022
Statement Of Use Processing Complete
Oct 17, 2022
Use Amendment Filed
Oct 26, 2022
Sou Extension 2 Granted
Oct 17, 2022
Sou Extension 2 Filed
Oct 26, 2022
Case Assigned To Intent To Use Paralegal
Oct 17, 2022
Teas Extension Received
Oct 17, 2022
Teas Statement Of Use Received
May 4, 2022
Notice Of Approval Of Extension Request E-Mailed
May 2, 2022
Sou Extension 1 Granted
May 2, 2022
Sou Extension 1 Filed
May 2, 2022
Teas Extension Received
Nov 2, 2021
Noa E-Mailed - Sou Required From Applicant
Sep 7, 2021
Changes/Corrections After Pub Approval Entered
Sep 7, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 7, 2021
Published For Opposition
Aug 25, 2021
Assigned To Petition Staff
Aug 18, 2021
Notification Of Notice Of Publication E-Mailed
Aug 15, 2021
Teas Post Publication Amendment Received
Aug 2, 2021
Approved For Pub - Principal Register
Jul 28, 2021
Examiner's Amendment Entered
Jul 28, 2021
Notification Of Examiners Amendment E-Mailed
Jul 28, 2021
Examiners Amendment E-Mailed
Jul 28, 2021
Examiners Amendment -Written
Jul 20, 2021
Assigned To Examiner
Apr 11, 2021
New Application Office Supplied Data Entered In Tram
Jan 14, 2021
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
